New Zealand markets open in 6 hours 36 minutes

Hepion Pharmaceuticals, Inc. (HEPA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0122-0.0478 (-4.58%)
As of 11:24AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 5.80M
Enterprise value -5.43M
Trailing P/E 0.37
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.00
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.10

Trading information

Stock price history

Beta (5Y monthly) 1.70
52-week change 3-91.18%
S&P500 52-week change 325.22%
52-week high 312.2450
52-week low 30.9000
50-day moving average 31.4119
200-day moving average 32.8963

Share statistics

Avg vol (3-month) 336.23k
Avg vol (10-day) 321.84k
Shares outstanding 55.47M
Implied shares outstanding 65.47M
Float 85.02M
% held by insiders 10.31%
% held by institutions 113.02%
Shares short (15 May 2024) 432.83k
Short ratio (15 May 2024) 40.61
Short % of float (15 May 2024) 40.60%
Short % of shares outstanding (15 May 2024) 40.60%
Shares short (prior month 15 Apr 2024) 463.97k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 303 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 311 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-71.07%
Return on equity (ttm)-172.45%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -37.15M
Net income avi to common (ttm)-38.52M
Diluted EPS (ttm)-9.4000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.11M
Total cash per share (mrq)2.39
Total debt (mrq)175.27k
Total debt/equity (mrq)2.33%
Current ratio (mrq)5.99
Book value per share (mrq)1.07

Cash flow statement

Operating cash flow (ttm)-36.29M
Levered free cash flow (ttm)-28.89M